NovoCure (NASDAQ:NVCR) Price Target Raised to $20.00
NovoCure (NASDAQ:NVCR – Free Report) had its target price boosted by Evercore ISI from $14.50 to $20.00 in a research report released on Tuesday morning, Benzinga reports. Evercore ISI currently has an in-line rating on the medical equipment provider’s stock. A number of other brokerages have also recently weighed in on NVCR. Piper Sandler reaffirmed […]
More Stories
Hochschild Mining (LON:HOC) Stock Price Crosses Above 200 Day Moving Average – Time to Sell?
Hochschild Mining plc (LON:HOC – Get Free Report)’s share price passed above its two hundred day moving average during trading...
Tortoise Pipeline & Energy Fund (NYSE:TTP) Shares Pass Above 200 Day Moving Average – Time to Sell?
Tortoise Pipeline & Energy Fund, Inc. (NYSE:TTP – Get Free Report) shares crossed above its 200-day moving average during trading...
K-Bro Linen (TSE:KBL) Stock Price Passes Above 200-Day Moving Average – Should You Sell?
K-Bro Linen Inc. (TSE:KBL – Get Free Report)’s stock price passed above its 200-day moving average during trading on Thursday...
Rep. Lloyd Doggett Purchases Shares of The Coca-Cola Company (NYSE:KO)
Representative Lloyd Doggett (D-Texas) recently bought shares of The Coca-Cola Company (NYSE:KO). In a filing disclosed on January 08th, the...
Seres Therapeutics Provides Corporate Updates and Financial Results
On January 9, 2025, Seres Therapeutics, Inc. (NASDAQ: MCRB) released significant updates regarding its recent achievements and financial standing. The...
Cohort (LON:CHRT) Stock Price Crosses Above 200-Day Moving Average – Here’s Why
Shares of Cohort plc (LON:CHRT – Get Free Report) crossed above its 200-day moving average during trading on Thursday ....